Pneumocystis jirovecii and cystic fibrosis

Medical Mycology

Volumn 48, Issue O1, 2010, Pages

  Caldern, Enrique J ^a   Friaza, Vicente ^a   Dapena, Francisco J ^b   De La Horra, Carmen ^a  

^a CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

cystic fibrosis; epidemiology; pathophysiology; Pneumocystis

Indexed keywords

AIRWAY OBSTRUCTION; ARTICLE; CYSTIC FIBROSIS; FOLLOW UP; FUNGAL COLONIZATION; GENOTYPE; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; LUNG DISEASE; LUNG FUNCTION; MICROFLORA; NONHUMAN; PATHOPHYSIOLOGY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; SMOKING;

CARRIER STATE; CYSTIC FIBROSIS; EUROPE; GENOTYPE; HUMANS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PREVALENCE;

FUNGI; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII;

EID: 78649934120     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2010.505205     Document Type: Article

References (48)

1. Calderon-Sandubete EJ, Varela-Aguilar JM, Medrano-Ortega FJ, et al. Historical perspective on Pneumocystis carinii infection. Protist 2002; 153: 303-310.
2. Edman JC, Kovacs JA, Masur H, et al. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 1988; 334: 519-522.
3. Stringer SL, Hudson K, Blase MA, et al. Sequence from ribosomal RNA of Pneumocystis carinii compared to those of four fungi suggests an ascomycetous aff nity. J Protozool 1989; 36: 14S-16S.
4. Aliouat-Denis CM, Chab é M, Demanche C, et al. Pneumocystis species, co-evolution and pathogenic power. Infect Genet Evol 2008; 8: 708-726.
5. Redhead SA, Cushion MT, Frenkel JK, Stringer JR. Pneumocystis and Trypanosoma cruzi : nomenclature and typif cations. J Eukaryot Microbiol 2006; 53: 2-11.
6. Thomas CF Jr., Limper AH. Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nat Rev Microbiol 2007; 5: 298-308.
7. Stringer JR, Beard CB, Miller RF, Wakef eld AE. A new name ( Pneu-mocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002; 8: 891-896.
8. Leibovitz E, Pollack H, Moore T, et al. Comparison of PCR and standard cytological staining for detection of Pneumocystis carinii from respiratory specimens from patients with or at high risk for infection by human immunodef ciency virus. J Clin Microbiol 1995; 33: 3004-3007.
9. Wakefeld AE, Pixley FJ, Banerji S, et al. Detection of Pneumocystis carinii with DNA amplif cation. Lancet 1990; 336: 451-453. (Pubitemid 20264212)
10. Vidal S, de la Horra C, Mart í n J, et al. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect 2006; 12: 231-235.
11. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical signif cance of Pneumocystis colonization. J Infect Dis 2008; 197: 10-17. (Pubitemid 351263460)
12. Takahashi T, Goto M, Endo T, et al. Pneumocystis carinii carriage in immunocompromised patients with and without human immunodef -ciency virus infection. J Med Microbiol 2002; 51: 611-614.
13. Wissmann G, Morilla R, Friaza V, Calderón E, Varela JM. El ser hu-mano como reservorio de Pneumocystis. Enferm Infecc Microbiol Clin 2010; 28: 38-43.
14. Rowe SM, Miller S, Sorscher EJ. Cysticf brosis. N Engl J Med 2005; 352: 1992-2001.
15. Mogayzel PJ Jr, Flume PA. Update in cysticf brosis 2009. Am J Respir Crit Care Med 2010; 181: 539-544.
16. Varela JM, Dapena J, Regord á n C, et al. Absence of Pneumocystis carinii carriers among patients with cysticf brosis. Eur J Clin Micro-biol Infect Dis 1998; 17: 741-742.
17. Royce FH, Blumberg DA. Pneumocystis carinii isolated from lung lavagef uid in an infant with cysticf brosis. Pediatr Pulmonol 2000; 29: 235-238.
18. Sing A, Geiger AM, Hogardt M, Heesemann J. Pneumocystis carinii carriage among cysticf brosis patients, as detected by nested PCR. J Clin Microbiol 2001; 39: 2717-2718.
19. Respaldiza N, Montes-Cano MA, Dapena FJ, et al. Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cysticf brosis patients in Spain. Clin Microbiol Infect 2005; 11: 1012-1015.
20. Gal SL, Héry-Arnaud G, Ramel S, et al. Pneumocystis jirovecii and cysticf brosis in France. Scand J Infect Dis 2010; 42: 225-227.
21. Nevez G, Chabé M, Rabodonirina M, et al. Nosocomial Pneumocystis jirovecii infections. Parasite 2008; 15: 359-365.
22. Calderón EJ, Varela JM, Medrano FJ, et al. Epidemiology of Pneu-mocystis carinii pneumonia in southern Spain. Clin Microbiol Infect 2004; 10: 673-676.
23. Varela JM, Regordán C, Medrano FJ, et al. Climatic factors and Pneu-mocystis jirovecii infection in southern Spain. Clin Microbiol Infect 2004; 10: 770-772.
24. Lubis N, Baylis D, Short A, et al. Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia. Postgrad Med J 2003; 79: 164-166.
25. Sing A, Schmoldt S, Laubender RP, et al. Seasonal variation of Pneu-mocystis jirovecii infection: analysis of underlying climatic factors. Clin Microbiol Infect 2009; 15: 957-960.
26. Montes-Cano MA, de la Horra C, Dapena FJ, et al. Dynamic colonisation by different Pneumocystis jirovecii genotypes in cysticf brosis patients. Clin Microbiol Infect 2007; 13: 1008-1011.
27. Montes-Cano MA, de la Horra C, Mart í n-Juan J, et al. Pneumocystis jirovecii genotypes in Spanish population. Clin Infect Dis 2004; 39: 123-128.
28. Beard CB, Fox MR, Lawrence GG, et al. Genetic differences in Pneu-mocystis isolates recovered from immunocompetent infants and from adult with AIDS: epidemiological implications. J Infect Dis 2005; 192: 1915-1918.
29. Montes-Cano MA, De la Horra C, Respaldiza N, et al. Polymorphisms in Pneumocystis jirovecii strains in Spanish children with cysticf bro-sis. J Infect Dis 2006; 193: 1332-1333.
30. Beard CB, Carter JL, Keely SP, et al. Genetic variation in Pneumocys-tis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000; 6: 265-272.
31. Catherinot E, Lanternier F, Bougnoux ME, et al. Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am 2010; 24: 107-138.
32. Morris AM, Huang L, Bacchetti P, et al. Permanent declines in pulmonary function following pneumonia in human immunodef ciency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 2000; 162: 612-616.
33. Varela JM, Respaldiza N, S á nchez B, et al. Lymphocyte response in subjects with chronic pulmonary disease colonized by Pneumocystis jirovecii. J Eukaryot Microbiol 2003; 50 (Suppl.): 672-673.
34. Morris A, Sciurba FC, Lebedeva IP, et al. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med 2004; 170: 408-413.
35. Calderón EJ, Rivero L, Respaldiza N, et al. Systemic inf amma-tion in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci. Clin Infect Dis 2007; 45: e17-19.
36. Morris A, Alexander T, Radhi S, et al. Airway obstruction is increased in Pneumocystis -colonized human immunodef ciency virus-infected outpatients. J Clin Microbiol 2009; 47: 3773-3776.
37. Patil SP, Board KF, Lebedeva IP, Norris KA. Immune responses to Pneumocystis colonization and infection in a simian model of AIDS. J Eukaryot Microbiol 2003; 50 (Suppl.): 661-662.
38. Norris KA, Morris A, Patil S, Fernandes E. Pneumocystis colonization, airway inf ammation, and pulmonary function decline in acquired im-munodef ciency syndrome. Immunol Res 2006; 36: 175-187.
39. Christensen PJ, Preston AM, Ling T, et al. Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inf ammation in mice. Infect Immun 2008; 76: 3481-3490.
40. Chabé M, Dei-Cas E, Creusy C, et al. Immunocompetent hosts as a reservoir of Pneumocystis organisms: Histological and RT-PCR data demonstrate active replication. Eur J Clin Microbiol Infect Dis 2004; 23: 89-97.
41. Rivero L, de la Horra C, Montes-Cano MA, et al. Pneumocystis jirovecii transmission from immunocompetent carriers to infant. Emerg Infect Dis 2008; 14: 1116-1118.
42. Harrison F. Microbial ecology of the cysticf brosis lung. Micro biology 2007; 153: 917-923.
43. Pihet M, Carrere J, Cimon B, et al. Occurrence and relevance off lamentous fungi in respiratory secretions of patients with cysticf brosis-a review. Med Mycol 2009; 47: 387-397.
44. Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cysticf brosis. Chest 2010; 137: 171-176.
45. Van Grunderbeeck N, Conseil V, Leroy S, Wallaert B, Delhaes L. Le risque fongique dans la mucoviscidose: é tude pilote. Ann Biol Clin (Paris) 2010; 68: 157-162.
46. Hogan DA, Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 2002; 296: 2229-2232.
47. McAlester G, O'Gara F, Morrissey JP. Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans. J Med Mi-crobiol 2008; 57: 563-569.
48. Friaza V, de la Horra C, Rodriguez-Dominguez MJ, et al. Meta-genomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization. J Microbiol Methods 2010; 82: 98-101.